Lattmann, Evelyn
Räss, Luca
Tognetti, Marco
Gómez, Julia M. Martínez
Lapaire, Valérie
Bruderer, Roland
Reiter, Lukas
Feng, Yuehan
Steinmetz, Lars M. http://orcid.org/0000-0002-3962-2865
Levesque, Mitchell P. http://orcid.org/0000-0001-5902-9420
Funding for this research was provided by:
Universität Zürich (University Research Priority Project)
University of Zurich
Article History
Received: 23 April 2023
Revised: 18 January 2024
Accepted: 19 January 2024
First Online: 14 February 2024
Declarations
:
: The study was conducted according to the standards for research ethics including human participants and the human research law of Switzerland. All human biological samples were collected from patients who provided written, informed consent, and with the approval of the local ethics committee (BASEC.Nr.2014–0425) and in accordance with the Declaration of Helsinki.Luca Räss, Marco Tognetti, Yuehan Feng, Roland Bruderer, and Lukas Reiter are employees of Biognosys AG (Schlieren, Switzerland). Mitchell P. Levesque has received project-specific funding unrelated to the topic of this paper from Roche, Novartis, Molecular Partners, Oncobit, and Scailyte.
: The study was conducted according to the standards for research ethics including human participants and the human research law of Switzerland. All human biological samples were collected from patients who provided written, informed consent, and with the approval of the local ethics committee (BASEC.Nr.2014–0425) and in accordance with the Declaration of Helsinki.
: Not applicable.